R. Agarwal, A. Goel, J. Rai, and N. C. Kajal, “Pharmacovigilance of first line anti-tubercular therapy in category I patients of pulmonary tuberculosis”, Int J Basic Clin Pharmacol, vol. 6, no. 3, pp. 643–647, Feb. 2017.